Objectives Severe trauma remains a leading cause of death in the Republic of Korea. In response, regional trauma centers were established in 2012. This study evaluated the impact of direct prehospital transport to trauma centers on in-hospital mortality among patients with severe trauma using the national trauma registry. Methods: This nationwide observational study utilized data from the Korean community-based trauma registry between 2016 and 2020. Patients with an injury severity score >15 who were directly transported from the prehospital setting were included. Variables analyzed encompassed demographics, injury mechanism, transport time, hospital level, and outcomes. The primary outcome was in-hospital mortality. Both logistic regression and decision tree models were employed. Results: A total of 24,567 patients were included. Overall mortality decreased by 5.2% during the study period. Patients transported to level 1 or 2 trauma centers had a lower mortality rate (23.6%) compared to those transported to level 3 or 4 hospitals (28.0%). The proportion of direct transports to high-level centers increased from 46.7% to 64.1% between 2016 and 2020. Despite longer transport times, patients transported to high-level institutions exhibited improved survival, particularly when transport exceeded 30 minutes, suggesting that hospital selection may be more critical than minimizing transport time. Conclusion: Direct transport to high-level trauma centers improves survival among patients with severe trauma, even when transport times are prolonged. These findings support the importance of a well-organized trauma system that emphasizes hospital capability in prehospital triage decisions.
Citations
Citations to this article as recorded by
Artificial intelligence and biohealth: the Republic of Korea’s emerging priorities in health care R&D Jong-Koo Lee Osong Public Health and Research Perspectives.2025; 16(4): 309. CrossRef
Objectives Mortality statistics during the coronavirus disease 2019 (COVID-19) pandemic are crucial for the allocation of medical care resources and public health decision-making. This study was initiated to investigate the excess mortality among older adults during the pandemic. Our research focuses on 2 primary areas. First, we analyzed the cumulative excess mortality across all age groups to assess the global impact and specifically examined the top 20 countries with the highest mortality rates during the pandemic. Second, we explored excess deaths among older adults by categorizing data from the years 2020 and 2021 into age groups: 65–74, 75–84, and above 85.
Methods We analyzed data from the top 20 countries with the highest mortality rates globally, focusing on 3 components: all-cause mortality means, expected deaths mean, and excess deaths mean for both older men and women.
Results Although excess mortality is higher among older men and women across all 3 age groups (65–74, 75–84, and >85), the highest mean excess mortality was observed in women over the age of 85.
Conclusion The results indicate that the severe acute respiratory syndrome coronavirus 2 virus had a disproportionately intense impact on older women. We developed 2 types of statistical models using the data: a binomial distribution model and a correlation coefficient model, both considering the mean excess deaths in older men and women across these 3 age groups. Estimating the excess mortality among older adults will aid in the formulation of healthcare policies for this demographic.
Citations
Citations to this article as recorded by
Immunogenicity, reactogenicity, and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED)–final report Jannik Stemler, Lusine Yeghiazaryan, Christoph Stephan, Kristin Greve-Isdahl Mohn, Rebecca Jane Cox, Antonio Javier Carcas-Sansuan, Esperanza Romero Rodriguez, José Moltó, Itziar Vergara Mitxeltorena, Isabelle Pink, Tobias Welte, Birutė Zablockienė, Murat International Journal of Infectious Diseases.2026; 165: 108466. CrossRef
Objectives The coronavirus disease 2019 (COVID-19) pandemic has had a severe impact on global health. Apart from the disease itself, the strict restrictions and lockdowns enforced to minimize its spread have also substantially disrupted personal and public health. Methods: An analysis of forensic autopsy investigations was conducted between 2019 and 2022 on a selected urban population in Colombo, Sri Lanka, assessing the effects of the COVID-19 pandemic on mortality within these communities. Results: During the COVID-19 restrictions, there was a 2.5-fold increase in the total number of deaths, with a significantly higher percentage of female deaths than before. The majority of these deaths were due to cardiovascular causes, while COVID-19-related deaths ranked third overall. The highest proportion of COVID-19 deaths occurred among unvaccinated females. The monthly frequency of deaths from traffic accidents, poisoning, and asphyxiation decreased, while deaths from blunt trauma, sharp trauma, burns, and immersion increased. There was also a rise in blunt homicides and a greater number of femicides during the COVID-19 restrictions than in the pre-pandemic period. A significantly higher percentage of males who received the COVID-19 vaccine died from cardiovascular causes compared to those in the unvaccinated group. Conclusion: The significant changes in mortality demographics and causes of death within this community during the COVID-19 restrictions underscore the disruption in healthcare, healthseeking behavior, and social interactions during this period. The vulnerability of individuals residing in highly urbanized areas with lower socioeconomic status, particularly women, is brought into sharp focus.
Citations
Citations to this article as recorded by
The impact of the COVID-19 pandemic on forensic pathology services in Limpopo province, South Africa Thakadu A. Mamashela, Samuel T. Ntuli South African Family Practice.2025;[Epub] CrossRef
A nationwide forensic case-series of femicides in Italy – Part 1: Clues to the motives of the murder Rossana Cecchi, Anna Laura Santunione, Jessika Camatti, Alice Buzzelli, Alessandra De Martina, Alessandra Sannella, Marco Vinceti, Graziamaria Corbi, Carlo Pietro Campobasso, Matilde Sassani, Giovanna Laura De Fazio, Paolo Fais, Susi Pelotti, Arianna Gior Legal Medicine.2025; 78: 102703. CrossRef
Objectives Although it is widely used as a measure for mortality, the case fatality rate (CFR) ofcoronavirus disease 2019 (COVID-19) can vary over time and fluctuate for many reasons otherthan viral characteristics. To compare the CFRs of different countries in equal measure, weestimated comparable CFRs after adjusting for multiple covariates and examined the mainfactors that contributed to variability in the CFRs among 21 countries.Methods: For statistical analysis, time-series cross-sectional data were collected from OurWorld in Data, CoVariants.org, and GISAID. Biweekly CFRs of COVID-19 were estimated bypooled generalized linear squares regression models for the panel data. Covariates includedthe predominant virus variant, reproduction rate, vaccination, national economic status,hospital beds, diabetes prevalence, and population share of individuals older than age 65. Intotal, 21 countries were eligible for analysis.Results: Adjustment for covariates reduced variation in the CFRs of COVID-19 across countriesand over time. Regression results showed that the dominant spread of the Omicron variant,reproduction rate, and vaccination were associated with lower country-level CFRs, whereasage, the extreme poverty rate, and diabetes prevalence were associated with higher countrylevel CFRs.Conclusion: A direct comparison of crude CFRs among countries may be fallacious, especiallyin a cross-sectional analysis. Our study presents an adjusted comparison of CFRs over timefor a more proper comparison. In addition, our findings suggest that comparing CFRs amongdifferent countries without considering their context, such as the epidemic phase, medicalcapacity, surveillance strategy, and socio-demographic traits, should be avoided.
Citations
Citations to this article as recorded by
From mono to multi-causality: Towards a comprehensive perspective on understanding death Peter Harteloh Health Policy.2024; 147: 105121. CrossRef
Comments on the article "Time-series comparison of COVID-19 case fatality rates across 21 countries with adjustment for multiple covariates" Gaetano Perone Osong Public Health and Research Perspectives.2023; 14(2): 146. CrossRef
Objectives
Coronavirus disease 2019 (COVID-19) is classified as a natural hazard, and social vulnerability describes the susceptibility of social groups to potential damages from natural hazards. Therefore, the objective of this study was to examine the association between social vulnerability and the cumulative number of confirmed COVID-19 deaths (per 100,000) in 3,141 United States counties.
Methods
The cumulative number of COVID-19 deaths was obtained from USA Facts. Variables related to social vulnerability were obtained from the Centers for Disease Control and Prevention Social Vulnerability Index and the 2018 5-Year American Community Survey. Data were analyzed using spatial autoregression models.
Results
Lowest income and educational level, as well as high proportions of single parent households, mobile home residents, and people without health insurance were positively associated with a high cumulative number of COVID-19 deaths.
Conclusion
In conclusion, there are regional differences in the cumulative number of COVID-19 deaths in United States counties, which are affected by various social vulnerabilities. Hence, these findings underscore the need to take social vulnerability into account when planning interventions to reduce COVID-19 deaths.
Citations
Citations to this article as recorded by
Patterns of Homologous Repair Deficiency and
BRCA1
/
2
Testing of Ovarian and Breast Cancers: A Real-World Study of Patients in Community Health Settings in the United States
Rayna K. Matsuno, Adrienne F.O. Williams, Connor Sweetnam, Giovanna I. Cruz, Liz M. Toland, Anna B. Berry, Monika A. Izano, Liam C. Lee, Gieira Jones, Jagadeswara R. Earla, Thomas D. Brown, Smita Kothari, Arthur Sillah JCO Oncology Advances.2025;[Epub] CrossRef
A low-rank Bayesian approach for geoadditive modeling Bryan Sumalinab, Oswaldo Gressani, Niel Hens, Christel Faes Spatial Statistics.2025; 68: 100907. CrossRef
A retrospective assessment of COVID-19 vulnerability index indicators and mortality rates pre-COVID-19 (2018–2020) and during COVID-19 (2020–2022) in a health and demographic surveillance site, Soweto, South Africa Takwanisa Machemedze, Chodziwadziwa Whiteson Kabudula, Jean Juste Harrisson Bashingwa, Beth A. Tippett Barr, Nellie Myburgh, Sana Mahtab, Cleopas Hwinya, Stephen Tollman, Ziyaad Dangor, Shabir A. Madhi Population Health Metrics.2025;[Epub] CrossRef
The Role of Testing and Vaccination in Mediating Social Vulnerability and COVID-19 Prevalence in Southern Nevada Andrea Lopez, Lung-Chang Chien, L.-W. Antony Chen, Courtney Coughenour, Erika Marquez, Szu-Ping Lee International Journal of Environmental Research an.2025; 22(7): 980. CrossRef
Ecological comparison of six countries in two waves of COVID-19 Meiheng Liu, Leiyu Shi, Manfei Yang, Jun Jiao, Junyan Yang, Mengyuan Ma, Wanzhen Xie, Gang Sun Frontiers in Public Health.2024;[Epub] CrossRef
Social vulnerability and COVID-19 in Maringá, Brazil Matheus Pereira Libório, Oseias da Silva Martinuci, Patrícia Bernardes, Natália Cristina Alves Caetano Chav Krohling, Guilherme Castro, Henrique Leonardo Guerra, Eduardo Alcantara Ribeiro, Udelysses Janete Veltrini Fonzar, Ícaro da Costa Francisco Spatial Information Research.2023; 31(1): 51. CrossRef
A county-level analysis of association between social vulnerability and COVID-19 cases in Khuzestan Province, Iran Mahmoud Arvin, Shahram Bazrafkan, Parisa Beiki, Ayyoob Sharifi International Journal of Disaster Risk Reduction.2023; 84: 103495. CrossRef
Global mapping of epidemic risk assessment toolkits: A scoping review for COVID-19 and future epidemics preparedness implications Bach Xuan Tran, Long Hoang Nguyen, Linh Phuong Doan, Tham Thi Nguyen, Giang Thu Vu, Hoa Thi Do, Huong Thi Le, Carl A. Latkin, Cyrus S. H. Ho, Roger C. M. Ho, Md Nazirul Islam Sarker PLOS ONE.2022; 17(9): e0272037. CrossRef
COVID-19 mortality and deprivation: pandemic, syndemic, and endemic health inequalities Victoria J McGowan, Clare Bambra The Lancet Public Health.2022; 7(11): e966. CrossRef
Objectives
Coronavirus disease 2019 (COVID-19) is a novel pandemic. Considerable differences in disease severity and the mortality rate have been observed in different parts of the world. The present study investigated the characteristics and outcomes of patients hospitalized with COVID-19 in Iran.
Methods
We established a retrospective cohort to study hospitalized COVID-19 patients in Iran. Epidemiological, imaging, laboratory, and clinical characteristics and outcomes were recorded from medical documents. The chi-square test, t-test, and logistic regression models were used to analyze the data. A p<0.05 was considered to indicate statistical significance.
Results
In total, 364 cases (207 males and 157 females) were analyzed. The most common symptoms were cough, fever, and dyspnea. Multifocal bilateral ground-glass opacities with peripheral distribution were the predominant imaging finding. The mean age of patients was 54.28±18.81 years. The mean age of patients who died was 71.50±14.60 years. The mortality rate was 17.6%. The total proportion of patients with a comorbidity was 47.5%, and 84.4% of patients who died had a comorbidity. Sex, history of diabetes mellitus, and dyslipidemia were not significantly associated with mortality (p>0.05). However, mortality showed significant relationships with body mass index; age; history of hypertension, chronic kidney disease (CKD), ischemic heart disease, cerebrovascular accident (CVA), pulmonary disease, and cancer; and abnormal high-resolution computed tomography (HRCT) findings (p<0.05 for all). Cancer had the highest odds ratio.
Conclusion
Comorbidities (especially cancer, CKD, and CVA), severe obesity, old age, and abnormal HRCT findings affected the health outcomes of patients hospitalized with COVID-19.
Citations
Citations to this article as recorded by
Obesity as a Risk Factor for Complications and Mortality in Individuals with SARS-CoV-2: A Systematic Review Marielle Priscila de Paula Silva-Lalucci, Déborah Cristina de Souza Marques, Pablo Valdés-Badilla, Leonardo Vidal Andreato, Braulio Henrique Magnani Branco Nutrients.2024; 16(4): 543. CrossRef
Effects of SARS-CoV-2 infections in patients with cancer on mortality, ICU admission and incidence: a systematic review with meta-analysis involving 709,908 participants and 31,732 cancer patients Mehmet Emin Arayici, Nazlican Kipcak, Ufuktan Kayacik, Cansu Kelbat, Deniz Keskin, Muhammed Emin Kilicarslan, Ahmet Veli Kilinc, Sumeyye Kirgoz, Anil Kirilmaz, Melih Alihan Kizilkaya, Irem Gaye Kizmaz, Enes Berkin Kocak, Enver Kochan, Begum Kocpinar, Fatm Journal of Cancer Research and Clinical Oncology.2023; 149(7): 2915. CrossRef
Risk Factors Associated with Severity and Death from COVID-19 in Iran: A Systematic Review and Meta-Analysis Study Ahmad Mehri, Sahar Sotoodeh Ghorbani, Kosar Farhadi-Babadi, Elham Rahimi, Zahra Barati, Niloufar Taherpour, Neda Izadi, Fatemeh Shahbazi, Yaser Mokhayeri, Arash Seifi, Saeid Fallah, Rezvan Feyzi, Koorosh Etemed, Seyed Saeed Hashemi Nazari Journal of Intensive Care Medicine.2023; 38(9): 825. CrossRef
The association between stroke and COVID-19-related mortality: a systematic review and meta-analysis based on adjusted effect estimates Shuwen Li, Jiahao Ren, Hongjie Hou, Xueya Han, Jie Xu, Guangcai Duan, Yadong Wang, Haiyan Yang Neurological Sciences.2022; 43(7): 4049. CrossRef
Mental health status of dentists during COVID‐19 pandemic: A systematic review and meta‐analysis Hamid Salehiniya, Sare Hatamian, Hamid Abbaszadeh Health Science Reports.2022;[Epub] CrossRef
Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients Lamiaa A Fathalla, Lamyaa M Kamal, Omina Salaheldin, Mahmoud A Khalil, Mahmoud M Kamel, Hagar H Fahim, Youssef AS Abdel-Moneim, Jawaher A Abdulhakim, Ahmed S Abdel-Moneim, Yomna M El-Meligui International Journal of Immunopathology and Pharm.2022;[Epub] CrossRef
Obesity and Infection: What Have We Learned From the COVID-19 Pandemic Emilia Vassilopoulou, Roxana Silvia Bumbacea, Aikaterini Konstantina Pappa, Athanasios N. Papadopoulos, Dragos Bumbacea Frontiers in Nutrition.2022;[Epub] CrossRef
Mental health of the people of northern Iran during the quarantine time of 2020 following the coronavirus epidemic Fereshteh Araghian Mojarad, Mohammad Ali Heidari Gorji, Hamid Salehiniya, Tahereh Yaghoubi Journal of Education and Health Promotion.2021;[Epub] CrossRef
Objectives
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused devastation in over 200 countries. Italy, Spain, and the United States (US) were most severely affected by the first wave of the pandemic. The reasons why some countries were more strongly affected than others remain unknown. We identified the most-affected and less-affected countries and states and explored environmental, host, and infrastructure risk factors that may explain differences in the SARS-CoV-2 mortality burden.
Methods
We identified the top 10 countries/US states with the highest deaths per population until May 2020. For each of these 10 case countries/states, we identified 6 control countries/states with a similar population size and at least 3 times fewer deaths per population. We extracted data for 30 risk factors from publicly available, trusted sources. We compared case and control countries/states using the non-parametric Wilcoxon rank-sum test, and conducted a secondary cluster analysis to explore the relationship between the number of cases per population and the number of deaths per population using a scalable EM (expectation–maximization) clustering algorithm.
Results
Statistically significant differences were found in 16 of 30 investigated risk factors, the most important of which were temperature, neonatal and under-5 mortality rates, the percentage of under-5 deaths due to acute respiratory infections (ARIs) and diarrhea, and tuberculosis incidence (<italic>p</italic><0.05)
Conclusion
Countries with a higher burden of baseline pediatric mortality rates, higher pediatric mortality from preventable diseases like diarrhea and ARI, and higher tuberculosis incidence had lower rates of coronavirus disease 2019-associated mortality, supporting the hygiene hypothesis.
Citations
Citations to this article as recorded by
COVID-19 vaccination coverage and the effect on regional disparities in morbidity and mortality among older people in Sweden, 2021–2023 Anton Nilsson, Dominik Dietler, Carl Bonander, Malin Inghammar, Jonas Björk Scandinavian Journal of Public Health.2026;[Epub] CrossRef
Prediction models of COVID-19 fatality in nine Peruvian provinces: A secondary analysis of the national epidemiological surveillance system Wendy Nieto-Gutierrez, Jaid Campos-Chambergo, Enrique Gonzalez-Ayala, Oswaldo Oyola-Garcia, Alberti Alejandro-Mora, Eliana Luis-Aguirre, Roly Pasquel-Santillan, Juan Leiva-Aguirre, Cesar Ugarte-Gil, Steev Loyola, Sizulu Moyo PLOS Global Public Health.2024; 4(1): e0002854. CrossRef
The effect of the urban exposome on COVID-19 health outcomes: A systematic review and meta-analysis Laura Houweling, Anke-Hilse Maitland-Van der Zee, Judith C.S. Holtjer, Somayeh Bazdar, Roel C.H. Vermeulen, George S. Downward, Lizan D. Bloemsma Environmental Research.2024; 240: 117351. CrossRef
Comparison of Gene Polymorphisms of ACE1 and ACE2 and the Level of Total ACE Activity in the Blood of Afghans and Iranians with COVID-19 and Its Relationship with Disease Severity Amin Morshedi Shahrebabaki, Mahsa Nikseresht, Mehdi Mahmoodi, Sadegh Zarei, Reza Hosseiniara, Ozra Sadat Esmaeili, Mohammad Reza Mirzaei, Mahmood Kahnooji, Mohammad Reza Hajizadeh Viral Immunology.2024; 37(10): 470. CrossRef
Demographic Characteristics and Status of Vaccinated Individuals with a History of COVID-19 Infection Pre- or Post-Vaccination: A Descriptive Study of a Nationally Representative Sample in Saudi Arabia Yazed AlRuthia, Haya F. Al-Salloum, Omar A. Almohammed, Amani S. Alqahtani, Hana A. Al-Abdulkarim, Yousef M. Alsofayan, Sami S. Almudarra, Sara H. AlQahtani, Abdullah Almutlaq, Khaled Alabdulkareem, Bander Balkhi, Hamoud T. Almutairi, Abdullah S. Alanazi, Vaccines.2022; 10(2): 323. CrossRef
Temporal variation, socioeconomic status, and out‐of‐hospital deaths as factors that influence mortality rates among hospitalized COVID‐19 patients receiving ACEIs/ARBs Owais M. Aftab, Anurag Modak, Jai C. Patel The Journal of Clinical Hypertension.2022; 24(4): 519. CrossRef
Coinfection of leptospirosis and coronavirus disease 2019: A retrospective case series from a coastal region in South India Nitin Gupta, William Wilson, Prithvishree Ravindra, Roshini Raghu, Kavitha Saravu Journal of Medical Virology.2022; 94(9): 4508. CrossRef
Dietary, comorbidity, and geo-economic data fusion for explainable COVID-19 mortality prediction Milena Trajanoska, Risto Trajanov, Tome Eftimov Expert Systems with Applications.2022; 209: 118377. CrossRef
Paraoxonase 1 rs662 polymorphism, its related variables, and COVID-19 intensity: Considering gender and post-COVID complications Zohreh-Al-Sadat Ghoreshi, Mojtaba Abbasi-jorjandi, Gholamreza Asadikaram, Mohsen Sharif-zak, Fatemeh Seyedi, Mohammad Khaksari Haddad, Mohammadreza Zangouey Experimental Biology and Medicine.2022; : 153537022211285. CrossRef
Clinical Effect of Q192R Paraoxonase 1 Polymorphism and its Related Variables on the COVID-19 Intensity Considering Gender and Post-COVID Complications Zohreh-al-sadat Ghoreshi, Mojtaba abasi, Gholamreza Asadikaram, Mohsen sharif-zak, Mitra Rezazadeh-Jabalbarzi, Hamidreza rashidinejad, Mohammadreza Zangouey SSRN Electronic Journal .2022;[Epub] CrossRef
Risk Factors and a Novel Score (CARI-65) Predicting Mortality in COVID-19 Patients Fayaz Ahmad Sofi, Umar Hafiz Khan, Sonaullah Shah, Nazia Mehfooz, Farhana Siraj, Afshan Shabir, Tajamul Hussain Shah, Muzaffar Bindroo, Mushtaq Ahmad, Rafi Ahmed Jan, Asma Shah, Faizan Wani Indian Journal of Respiratory Care.2022; 11(2): 154. CrossRef
Variances in BCG protection against COVID-19 mortality: A global assessment Zouina Sarfraz, Azza Sarfraz, Krunal Pandav, Sarabjot Singh Makkar, Saman Hasan Siddiqui, Gaurav Patel, Tania Platero-Portillo, Bishnu Mohan Singh, Mohamed Iburahim Haja Maideen, Deepika Sarvepalli, Muzna Sarfraz, Jose Cardona-Guzman, Marcos A. Sanchez-Go Journal of Clinical Tuberculosis and Other Mycobac.2021; 24: 100249. CrossRef
<sec><title>Objectives</title><p>Cancer has attracted worldwide attention. The incidence and prevalence are increasing, and it is the main cause of death. The purpose of this study was to identify the characteristics of hospitalized cancer patients.</p></sec><sec><title>Methods</title><p>This study is a secondary data study using the Korean National Hospital Discharge In-depth Injury Survey Data conducted annually by the Korea Centers for Disease Control and Prevention. Using these data, we extracted inpatients who principal diagnosis is cancer for nine years from 2005 to 2013.</p></sec><sec><title>Results</title><p>According to the analysis, the annual trend of cancer inpatients is steadily increasing. In 2025, it is expected to increase to about 670,000 inpatients. A cancer diagnosis created a change in medical utilization depending on the characteristics of patients and hospital. Men are more at risk of cancer than women. The number of hospital beds and hospital days were inversely proportional to cancer inpatients. There was also a difference in the equity of medical utilization by region. Other cancer management policies should be based on sex.</p></sec><sec><title>Conclusion</title><p>Populations between the ages of 45 and 64 years should be a priority in cancer policy. Because of the long-term hospitalization of patients with death as the outcome, a terminal cancer patient care facility is needed. These conclusions can provide a basis for various health policies.</p></sec>
Citations
Citations to this article as recorded by
Health-related quality of life by veterans RAND 12 and healthcare resource utilization in cancer patients with sleep disorders: insights from the Medical Expenditure Panel Survey Yuan Kao, Ying-Jia Lin, Shih-Feng Weng, Jhi-Joung Wang, I-Chen Lee, Chien-Cheng Huang Supportive Care in Cancer.2024;[Epub] CrossRef
Objectives
One of the most common head and neck cancers is nasopharynx cancer. Knowledge about the incidence and mortality of this disease and its distribution in terms of geographical areas is necessary for further study and better planning. Therefore, this study was conducted with the aim of determining the incidence and mortality rates of nasopharynx cancer and its relationship with the Human Development Index (HDI) in Asia in 2012. Methods
The aim of this ecologic study was to assess the correlation between age-specific incidence rate (ASIR) and age-specific mortality rate (ASMR) with HDI and its components, which include the following: life expectancy at birth, mean years of schooling, and gross national income per capita. Data about SIR and SMR for every Asian country for 2012 were obtained from the global cancer project. We used the correlation bivariate method for the assessment. Statistical significance was assumed if <i>p</i> < 0.05. All reported <i>p</i> values are two-sided. Statistical analyses were performed using SPSS (Version 15.0, SPSS Inc.). Results
A total of 68,272 cases (males, 71.02%; females, 28.97%; sex ratio, 2.45) and 40,530 mortalities (males, 71.63%; females, 28.36%; sex ratio, 2.52) were recorded in Asian countries in 2012. The five countries with the highest ASIR of nasopharynx cancer were Malaysia, Singapore, Indonesia, Vietnam, and Brunei, and the five countries with the highest ASMR were Indonesia, Vietnam, Singapore, Malaysia, and Brunei. The correlation between HDI and ASIR was 0.097 (<i>p</i> = 0.520) [0.105 in men (<i>p</i> = 0.488) and 0.119 in women (<i>p</i> = 0.901)]. The correlation between HDI and ASMR was –0.102 (<i>p</i> = 0.502) [–0.072 in men (<i>p</i> = 0.633) and –0.224 in women (<i>p</i> = 0.134)]. Conclusion
Nasopharynx cancer is native to Southeast Asia. The highest incidence and mortality rates are found in Malaysia, Singapore, Indonesia, Vietnam, and Brunei. No significant relation was found between the standardized incidence and mortality rates of nasopharynx cancer and the HDI components. Further studies are recommended in Southeast Asian countries in order to find the etiology of cancer, as well as its diagnosis and treatment.
Citations
Citations to this article as recorded by
Nasopharynx Cancer in the United States: Racial and Ethnic Disparities in Stage at Presentation Edward Christopher Dee, Stephanie Wang, Frances Dominique V. Ho, Roshal R. Patel, Kaitlyn Lapen, Yingzhi Wu, Fan Yang, Tej A. Patel, Erin Jay G. Feliciano, Sean M. McBride, Nancy Y. Lee The Laryngoscope.2025; 135(3): 1113. CrossRef
WITHDRAWN: Clinical Characteristics and Mechanisms of Syncope in Nasopharyngeal Carcinoma: A Systematic Review Achmad Chusnu Romdhoni, Pandit Bagus Tri Saputra, Jannatin Nisa Arnindita, Ali Mustofa, Danial Habri Arsyi, Farizky Martriano Humardani, Nando Reza Pratama Heliyon.2025; : e42939. CrossRef
Potential toxicity benefit and inter-fraction robustness of proton arc therapy compared to IMPT and VMAT for nasopharyngeal cancer patients B A de Jong, A Maring, Werkman CI, J Sundström, D Cannavò, A van der Schaaf, D Scandurra, E Engwall, E W Korevaar, G Janssens, J A Langendijk, S Both Physics in Medicine & Biology.2025; 70(10): 105007. CrossRef
Incidence patterns of rare cancer in southeast Asian and western Pacific countries (RARECAREnet Asia project): a study using population-based cancer registry data, 2011–2015 Patumrat Sripan, Siti Norbayah Yusof, Donsuk Pongnikorn, Imjai Chitapanarux, Balqis Bahtiar, Nor Saleha Ibrahim Tamin, Karnchana Daoprasert, Narate Waisri, Young-Joo Won, RuRu Chun-Ju Chiang, Annalisa Trama, Hadrien Charvat, Kriengkrai Srithanaviboonchai, The Lancet Regional Health - Southeast Asia.2025; 41: 100670. CrossRef
From Viral Infection to Malignancy: The Dual Threat of EBV and COVID-19 in Cancer Development Moyed Alsaadawe, Bakeel A. Radman, Longtai Hu, Jingyi Long, Qingshuang Luo, Chushu Tan, Hadji Sitti Amirat, Mohenned Alsaadawi, Xiaoming Lyu Viruses.2025; 17(9): 1195. CrossRef
Nasopharyngeal Carcinoma and Head and Neck Cancer in Type 2 Diabetes after SGLT2I, DPP4I, and GLP1a Use Lifang Li, Oscar Hou-In Chou, Kar Kei Mak, Yifan Yang, Cheuk To Chung, Guoliang Li, Catherine Po Ling Chan, Wing Tak Wong, Tong Liu, Bernard Man Yung Cheung, Gary Tse, Jiandong Zhou Cancer Prevention Research.2025; 18(10): 625. CrossRef
Non-Invasive Detection of Nasopharyngeal Carcinoma Using Volatile Organic Compounds Chuan Hao Gui, Zhunan Jia, Alex Chengyao Tham, Khai Beng Chong, Zihao Xing, Fuchang Zhang, Fang Du, Yaw Khian Chong, Hao Li, Ernest Weizhong Fu, Jereme Yijin Gan, Agnes Si Qi Chew, Ming Yann Lim Metabolites.2025; 15(9): 632. CrossRef
Sound Progress? Asian Representation in Otolaryngology Residency Programs: A 5‐Year Update Amy Wang, Yuki Yoshiyasu, Brian McKinnon, Tyler Janz Laryngoscope Investigative Otolaryngology.2025;[Epub] CrossRef
Detection of 30bp deletion LMP1 oncogene as potential diagnostic and prognostic Biomarker among nasopharyngeal carcinoma patients Aseel Al-Hussien, Mai Abusalah, Yaqeen Rjoub, Khaled Al-Qaoud, Anwar Rjoop, Yasmin AlSaidat, Lubna H Khwaileh, Manal Abusalah, Naveed Ahmed Electronic Journal of General Medicine.2025; 22(6): em703. CrossRef
Development of machine learning models for survival prediction in nasopharyngeal carcinoma using population-based data Guoxiang Lin, Qiyan Mo, Lu Han, Shaohan Sun, Zhiqiang Xiao, Weiming Zhang Discover Oncology.2025;[Epub] CrossRef
Nasopharyngeal Carcinoma in Southeast Asia: Current Landscape and Future Priorities Suat Ming Chan, Ian C. Paterson, Lee Fah Yap British Journal of Biomedical Science.2025;[Epub] CrossRef
Regulatory role of miRNAs in nasopharyngeal cancer involving PTEN/PI3K/AKT, TGFβ/SMAD, RAS/MAPK, Wnt/β‐catenin and pRB‐E2F signaling pathways: A review Rabiatul Basria S. M. N. Mydin, Adam Azlan, Simon I. Okekpa, Nigel J. Gooderham Cell Biochemistry and Function.2024;[Epub] CrossRef
Rapid and sensitive detection of Epstein-Barr virus antibodies in nasopharyngeal carcinoma by chemiluminescence strips based on iron-porphyrin single atom nanozyme Daji Wang, Jie Wang, Dan Liu, Jiuyang He, Meiying Wang, Haibing Huang, Guohui Nie, Hui Ding, Xiyun Yan Nano Research.2024; 17(3): 1827. CrossRef
The association between chronic sinonasal inflammation and nasopharyngeal carcinoma - A systematic review and meta-analysis Yuxing Wang, Kylynn Kathleen Koh, Elizabeth Chua, Kimberley Liqin Kiong, Yu Heng Kwan, Tze Choong Charn American Journal of Otolaryngology.2024; 45(2): 104206. CrossRef
Factors influencing presentation delay among cancer patients: a cross-sectional study in Malaysia Tshewang Gyeltshen, Hoon Shien Teh, Ching Ee Loo, Nicholas Yee Liang Hing, Wei Yin Lim, Shridevi Subramaniam, Wen Jun Wong, Zoie Shui-Yee Wong, Wen Yea Hwong BMC Public Health.2024;[Epub] CrossRef
Correlation between socioeconomic indices and epidemiological indices of thyroid cancer from 1990 to 2019 year: a global ecologic study Zahra Maleki, Jafar Hassanzadeh, Haleh Ghaem BMC Cancer.2024;[Epub] CrossRef
Study on carotid artery stenosis after radiotherapy for nasopharyngeal carcinoma JunMei Song, Luo Lan, YuQing Lv, YaJing Wen, Min Kang, RenSheng Wang Journal of Cancer Research and Clinical Oncology.2024;[Epub] CrossRef
Nasopharyngeal cancer mortality in disaggregated Asian and non‐Asian Americans George A. Hung, Sanah Vohra, Gina Kim, Armaan Jamal, Malathi Srinivasan, Robert J. Huang, Gloria Kim, Latha Palaniappan, A. Dimitrios Colevas Head & Neck.2024; 46(12): 3046. CrossRef
Study of Three Potential Diagnostic Biomarkers in Nasopharyngeal Carcinoma Samples from Guilan, North of Iran Saghi Jani Kargar Moghaddam, Amaneh Mohammadi Roushandeh, Mehryar Habibi Roudkenar, Shadman Nemati, Nima Najafi-Ghalehlou, Toofan Pakzad, Masoud Hamidi International Archives of Otorhinolaryngology.2023; 27(03): e461. CrossRef
Oncogenic Viruses-Encoded microRNAs and Their Role in the Progression of Cancer: Emerging Targets for Antiviral and Anticancer Therapies Mahmoud Kandeel Pharmaceuticals.2023; 16(4): 485. CrossRef
Nasopharyngeal Carcinoma Subtype Discovery via Immune Cell Scores from Tumor Microenvironment Yanbo Sun, Yun Liu, Hanqi Chu, Zhen-Jian Zhuo Journal of Immunology Research.2023; 2023: 1. CrossRef
The application of Aptamer in biomarker discovery Yongshu Li, Winnie Wailing TAM, Yuanyuan Yu, Zhenjian Zhuo, Zhichao Xue, Chiman Tsang, Xiaoting Qiao, Xiaokang Wang, Weijing Wang, Yongyi Li, Yanyang Tu, Yunhua Gao Biomarker Research.2023;[Epub] CrossRef
Blood-based DNA methylation in advanced Nasopharyngeal Carcinoma exhibited distinct CpG methylation signature Koustav Chatterjee, Sudipa Mal, Monalisha Ghosh, Nabanita Roy Chattopadhyay, Sankar Deb Roy, Koushik Chakraborty, Syamantak Mukherjee, Moatoshi Aier, Tathagata Choudhuri Scientific Reports.2023;[Epub] CrossRef
Circular RNA circ_0008450 regulates the proliferation, migration, invasion, apoptosis and chemosensitivity of CDDP-resistant nasopharyngeal carcinoma cells by the miR-338-3p/SMAD5 axis Lin Liu, Bin Lu, Yan Li Anti-Cancer Drugs.2022; 33(1): e260. CrossRef
Hypermethylation of the RASSF1A gene promoter as the tumor DNA marker for nasopharyngeal carcinoma Thuan Duc Lao, Hue Hong Thieu, Dung Huu Nguyen, Thuy Ai Huyen Le The International Journal of Biological Markers.2022; 37(1): 31. CrossRef
miR-135b-5p Targets SIRT1 to Inhibit Deacetylation of c-JUN and Increase MMP7 Expression to Promote Migration and Invasion of Nasopharyngeal Carcinoma Cells Yali Cheng Molecular Biotechnology.2022; 64(6): 693. CrossRef
Trends in the Incidence of Nasopharyngeal Cancer in Saudi Arabia Across One Decade (2007 to 2016) Abdualrahman F Kabli, Khalil F Miyajan, Abdulmohsen S Alqurashi, Ammar K Mandili, Revan M Mujahed, Bayan F Hafiz, Roaa M Mandora, Ameen Z Herabi Cureus.2022;[Epub] CrossRef
Causes of Death in Long-Term Nasopharyngeal Carcinoma Survivors Shi-Ping Yang, Ming-Yue Rao, Qing-Shuang Chen, Ping Zhou, Chen-Lu Lian, San-Gang Wu Frontiers in Public Health.2022;[Epub] CrossRef
Epstein-Barr Virus (EBV) Is Mostly Latent and Clonal in Angioimmunoblastic T Cell Lymphoma (AITL) Racha Bahri, François Boyer, Mohamad Adnan Halabi, Alain Chaunavel, Jean Feuillard, Arnaud Jaccard, Sylvie Ranger-Rogez Cancers.2022; 14(12): 2899. CrossRef
Ferroptosis-related gene ATG5 is a novel prognostic biomarker in nasopharyngeal carcinoma and head and neck squamous cell carcinoma Ming Shi, Jiangnan Du, Jingjing Shi, Yunchuanxiang Huang, Yan Zhao, Lan Ma Frontiers in Bioengineering and Biotechnology.2022;[Epub] CrossRef
Platelet to Lymphocytes Ratio to Predict Nasopharyngeal Carcinoma Progressivity Goesti Yudistira, Yussy Afriani Dewi, Melati Sudiro Open Access Macedonian Journal of Medical Sciences.2022; 10(B): 2189. CrossRef
Skin Sparing in Intensity-Modulated Radiation Therapy of Nasopharyngeal Carcinoma Misba Hamid Baba, Benoy K Singh, Shaq ul Qamar Wani Journal of Medical Physics.2022; 47(3): 243. CrossRef
Assessment of Response to Chemoradiation and Radiation Therapy in Patients with Nasopharyngeal Carcinoma Sebastian Ario Susanto, Yussy Afriani Dewi, Raden Ayu Hardianti Saputri Open Access Macedonian Journal of Medical Sciences.2022; 10(B): 2307. CrossRef
Genetic variants in NKG2D axis and susceptibility to Epstein–Barr virus-induced nasopharyngeal carcinoma Nguyen Hoang Viet, Nguyen Quang Trung, Le Thanh Dong, Ly Quoc Trung, J. Luis Espinoza Journal of Cancer Research and Clinical Oncology.2021; 147(3): 713. CrossRef
Corticosteroid Therapy in Optic Neuropathy Secondary to Nasopharyngeal Carcinoma Zulaikha Wahab, Evelyn Tai, Wan-Hazabbah Wan Hitam, Khairy Shamel Sonny Teo Cureus.2021;[Epub] CrossRef
The Effect of Hispidulin, a Flavonoid from Salvia plebeia, on Human Nasopharyngeal Carcinoma CNE-2Z Cell Proliferation, Migration, Invasion, and Apoptosis Yiqun Dai, Xiaolong Sun, Bohan Li, Hui Ma, Pingping Wu, Yingping Zhang, Meilin Zhu, Hong-Mei Li, Minjian Qin, Cheng-Zhu Wu Molecules.2021; 26(6): 1604. CrossRef
δ-Tocotrienol induces apoptosis and inhibits proliferation of nasopharyngeal carcinoma cells Junjun Shen, Tao Yang, Yiping Tang, Tianyi Guo, Ting Guo, Tao Hu, Feijun Luo, Qinlu Lin Food & Function.2021; 12(14): 6374. CrossRef
WNT8B as an Independent Prognostic Marker for Nasopharyngeal Carcinoma Chawalit Ngernsombat, Pongphol Prattapong, Noppadol Larbcharoensub, Krittika Khotthong, Tavan Janvilisri Current Oncology.2021; 28(4): 2529. CrossRef
Nasopharyngeal Carcinoma and Its Association with Epstein-Barr Virus Harish N. Vasudevan, Sue S. Yom Hematology/Oncology Clinics of North America.2021; 35(5): 963. CrossRef
Association between stage and histopathological type of nasopharyngeal cancer on occurrence of postirradiation otitis media with effusion Lina Lasminingrum, Shinta Fitri Boesoeri, Sally Mahdiani, Eveline Sabrina Ranti International Journal of Surgery Open.2021; 36: 100376. CrossRef
Current Status and Future Perspectives about Molecular Biomarkers of Nasopharyngeal Carcinoma Pui Yan Siak, Alan Soo-Beng Khoo, Chee Onn Leong, Boon-Peng Hoh, Shiau-Chuen Cheah Cancers.2021; 13(14): 3490. CrossRef
Carcinomatous‑like mastitis due to axillary lymphadenopathy in a case of nasopharyngeal carcinoma: A case report Cristina Oprean, Nusa Segarceanu, Alexandra Stan, Cristian Suciu, Daciana Grujic, Ioana Rivis, Alis Liliana Dema, Ana Bredicean Experimental and Therapeutic Medicine.2021;[Epub] CrossRef
Dosimetric Comparison of Helical Tomotherapy, Volume-Modulated Arc Therapy, and Fixed-Field Intensity-Modulated Radiation Therapy in Locally Advanced Nasopharyngeal Carcinoma Shan Lu, Huiqi Fan, Xueyuan Hu, Xin Li, Yingying Kuang, Deyang Yu, Shanshan Yang Frontiers in Oncology.2021;[Epub] CrossRef
The dosimetric comparison between tomotherapy and RapidArc in normal tissue sparing for nasopharyngeal carcinoma Pubade Kaewpruk, Somvilai Chakrabandhu, Somsak Wanwilairat, Wannapha Nobnop Journal of Radiotherapy in Practice.2020; 19(3): 237. CrossRef
Combination of Plasma MIF and VCA-IgA Improves the Diagnostic Specificity for Patients With Nasopharyngeal Carcinoma Ning Xue, Shan Xing, Weiguo Ma, Jiahe Sheng, Zhiliang Huang, Qingxia Xu Technology in Cancer Research & Treatment.2020;[Epub] CrossRef
Pathological features of nasopharyngeal carcinoma: A single-center study in Vietnam Nguyen Cuong Pham, Thanh Xuan Nguyen, Nguyen Tuong Pham, Thanh Chinh Phan, Hai Thanh Phan Annals of Cancer Research and Therapy.2020; 28(2): 125. CrossRef
Association between variant alleles of major histocompatibility complex class II regulatory genes and nasopharyngeal carcinoma susceptibility Ping Zhou, Sha Liu, Nan-Nan Ji, Shuang Zhang, Peng Wang, Bing Lin, Ping Yang, Xian-Tao Lin, Yi-Zheng Cai, Zi-Ming Wang, Han Zhou, Shi-Yao Sun, Xin-Bao Hao European Journal of Cancer Prevention.2020; 29(6): 531. CrossRef
Hyperperfusion Syndrome and Baroreflex Failure following Carotid Artery Angioplasty and Stenting for Symptomatic Radiation-Associated Carotid Artery Stenosis Hui-Meng Chang Case Reports in Neurology.2020; 12(Suppl. 1): 76. CrossRef
Novel patterns of the Epstein-Barr nuclear antigen (EBNA-1) V-Val subtype in EBV-associated nasopharyngeal carcinoma from Vietnam LD Thuan, ND Kha, NT Minh, LHA Thuy Balkan Journal of Medical Genetics.2019; 22(1): 61. CrossRef
miR-29c regulates resistance to paclitaxel in nasopharyngeal cancer by targeting ITGB1 Limin Huang, Chaoquan Hu, Hui Chao, Rongpin Wang, He Lu, Hong Li, Hui Chen Experimental Cell Research.2019; 378(1): 1. CrossRef
Systematic review and meta-analysis of prognostic microRNA biomarkers for survival outcome in nasopharyngeal carcinoma Shanthi Sabarimurugan, Chellan Kumarasamy, Siddhartha Baxi, Arikketh Devi, Rama Jayaraj, Yukinori Takenaka PLOS ONE.2019; 14(2): e0209760. CrossRef
Epstein‐Barr virus strain variation and cancer Teru Kanda, Misako Yajima, Kazufumi Ikuta Cancer Science.2019; 110(4): 1132. CrossRef
Nasopharyngeal cancer in Saudi Arabia: Epidemiology and possible risk factors Abdullah Dakheel Alotaibi, Hussain Gadelkarim Ahmed, Abdelbaset Mohamed Elasbali Journal of Oncological Sciences.2019; 5(1): 23. CrossRef
Association BetweenLMP-1,LMP-2, and miR-155 Expression as Potential Biomarker in Nasopharyngeal Carcinoma Patients: A Case/Control Study in Vietnam Thuan Duc Lao, Thuy Ai Huyen Le Genetic Testing and Molecular Biomarkers.2019; 23(11): 815. CrossRef
Lapatinib sensitivity in nasopharyngeal carcinoma is modulated by SIRT2-mediated FOXO3 deacetylation Sathid Aimjongjun, Zimam Mahmud, Yannasittha Jiramongkol, Glowi Alasiri, Shang Yao, Ernesto Yagüe, Tavan Janvilisri, Eric W.-F. Lam BMC Cancer.2019;[Epub] CrossRef
PPARβ/δ Agonist GW501516 Inhibits Tumorigenicity of Undifferentiated Nasopharyngeal Carcinoma in C666-1 Cells by Promoting Apoptosis Yangyang Ji, Hui Li, Fang Wang, Linglan Gu Frontiers in Pharmacology.2018;[Epub] CrossRef
Pembrolizumab in Asia‐Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE‐012 Makoto Tahara, Kei Muro, Yasuhisa Hasegawa, Hyun Cheol Chung, Chia‐Chi Lin, Bhumsuk Keam, Kenichi Takahashi, Jonathan D. Cheng, Yung‐Jue Bang Cancer Science.2018; 109(3): 771. CrossRef
Childhood Nasopharyngeal Carcinoma (NPC): A Review of Clinical-Imaging Features and Recent Trends in Management Mark Yoi Sun Soo International Journal of Pediatrics and Child Heal.2018; 6: 1. CrossRef
KISS1gene suppresses metastasis of nasopharyngeal cancerviaactivation of the ERK1/2 pathway Tingting Li, Qian Sun, Yan Zhou, Zelai He, Hao Liu, Ping Xiang, Jin Xi, Xiazi Zhang, Hao Jiang RSC Advances.2017; 7(84): 53445. CrossRef
First
Prev
